B

Betta Pharmaceuticals Co Ltd
SZSE:300558

Watchlist Manager
Betta Pharmaceuticals Co Ltd
SZSE:300558
Watchlist
Price: 49.36 CNY -7.04% Market Closed
Market Cap: 20.7B CNY
Have any thoughts about
Betta Pharmaceuticals Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

46.4
Current
71.3
Median
16.6
Industry
Lower than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
46.4
=
Enterprise Value
22B CNY
/
EBIT
474.6m CNY
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
37.1
2-Years Forward
EV/EBIT
24.7
3-Years Forward
EV/EBIT
16.6

See Also

Discover More